跳转至内容
Merck
CN
Histone Lysine Demethylase Inhibitor VIII, GSK-J4 Histone Lysine Demethylase Inhibitor VIII, GSK-J4, CAS 1373423-53-0, is converted to GSK-J1 intracellularly for effective JMJD3 and UTX inhibition (~ 25 to 50 µM in HeLa cultures).

GSK-J4

Histone Lysine Demethylase Inhibitor VIII, GSK-J4 Histone Lysine Demethylase Inhibitor VIII, GSK-J4, CAS 1373423-53-0, is converted to GSK-J1 intracellularly for effective JMJD3 and UTX inhibition (~ 25 to 50 µM in HeLa cultures).
别名:
3-((6-(4,5-二氢-1H-苯并[d]氮杂卓-3(2H)-基)-2-(吡啶-2-基)嘧啶-4-基)氨基)丙酸乙酯, Histone Lysine Demethylase Inhibitor VIII, GSK-J4
经验公式(希尔记法):
C24H27N5O2
化学文摘社编号:
分子量:
417.50

Products

产品分类
品牌
颜色
分子量
物质形态
纯度
研究领域
质量水平